Ex-NBA Star Kendrick Perkins Sends Brutal Message to Donovan Mitchell on Playoff Struggles
The Cleveland Cavaliers hitched their wagon to Donovan Mitchell last season when they fired head coach J.B. Bickerstaff for him.
Advertisement
They hired Kenny Atkinson to replace him in hopes of convincing the former Utah Jazz star to sign an extension.
He eventually re-upped with Cleveland and they clearly believed he was the guy who could lead them to the promised land.
Less than a year later, the Cavs suffered another disappointing playoff exit and with such an expensive roster there aren't many additions that can be made.
This means that unless the roster magically ascends to true championship contention, the only way forward is to retool or blow the team up and start over.
May 9, 2025; Indianapolis, Indiana, USA; Cleveland Cavaliers guard Donovan Mitchell (45) during game three of the second round for the 2025 NBA Playoffs against the Indiana Pacers at Gainbridge Fieldhouse. Mandatory Credit: Trevor Ruszkowski-Imagn Images© Trevor Ruszkowski-Imagn Images
Mitchell is statistically one of the best playoff performers to ever play basketball, so it's hard to blame him for his teams' shortcomings in the postseason.
Advertisement
However, he has put himself into unwanted company by becoming one of the longest tenured stars in NBA history to never reach the conference finals.
Retired NBA star Kendrick Perkins ripped into Mitchell recently, saying, 'A Donovan Mitchell-led team has never been to the conference finals.'
The six-time All-Star has reached the playoffs in every year of his playing career, but the second round is the furthest he's gotten.
The past few seasons have seen the pressure ratchet up on Philadelphia 76ers' superstar Joel Embiid for not making the conference in his nine-year playing career and now Mitchell is beginning to catch the same heat.
Advertisement
The only superstar with a longer streak is Chris Paul who finally reached the conference finals with the Houston Rockets in 2018, 13 years into his career.
Some of the criticism is unfair, but when you are as great as Mitchell is and consistently have highly seeded teams, the expectation is to win on a grand scale.
Until the Cavs finally break through, Mitchell will continue to be scrutinized.
Related: Cavs Give Promising Update on Donovan Mitchell's Playoff Status
This story was originally reported by Athlon Sports on Jun 1, 2025, where it first appeared.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Sean Payton: Dre Greenlaw plays like Mike Tyson
Linebacker Dre Greenlaw made the most of the first day in pads at Broncos training camp. Greenlaw filled gaps and delivered hits throughout team drills in Denver and head coach Sean Payton said you didn't even have to be watching to know that Greenlaw was the one landing blows. Payton said "you can hear it" when Greenlaw makes a hit and then went on to compare his style to another knockout artist from a different sport. "He plays like Mike Tyson," Payton said, via the team's website. "He's tough, he's physical. He's built that way. There's not a lot of leaky yardage. Some guys [allow that]. He's a knock-back tackler. They stop where he hits them. There's an intensity to how he plays. He's one of those players that if you put the film on and didn't say anything, at some point early, you'd ask, 'Who is this guy?'" Greenlaw was limited to two games for the 49ers last year because of injuries and a quad injury interrupted his first offseason in Denver, so one key for the Broncos will be making sure Greenlaw's healthy enough to deploy that physicality on a regular basis. If he is, facing an already tough Broncos defense will be even less enjoyable for opposing offenses in 2025.
Yahoo
an hour ago
- Yahoo
Commanders put OL Nate Herbig on reserve/retired list
Veteran offensive lineman Nate Herbig is walking away from football. Herbig signed with the Commanders this offseason, but the team announced on Tuesday morning that he has been placed on the team's reserve/retired list. He will no longer count against the team's 90-man roster limit. Herbig spent the last two seasons with the Steelers, but did not play at all in 2024 after a rotator cuff injury. Herbig appeared in 17 games for the Steelers in 2023 and he started 11 games at guard for the Jets in 2022. The Eagles signed Herbig as an undrafted free agent in 2019 and he started 17 of the 33 games he played while with Philadelphia. Nick Allegretti and Chris Paul remain on hand as depth options at guard in Washington.
Yahoo
an hour ago
- Yahoo
SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results
NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, August 5, 2025. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at in the Investor Relations section of the site, or by clicking here. Please log in approximately 5-10 minutes prior to the scheduled start time. Participants may access the call by dialing 1-800-717-1738 for domestic callers or 1-646-307-1865 for international callers. A replay of the call will be available for two weeks by dialing 1-844-512-2921 for domestic callers or 1-412-317-6671 for international callers and using Conference ID: 1130215. The archived webcast will be available in the Investor Relations section of the Company's website. About SIGA SIGA is a commercial-stage pharmaceutical company and leader in global health focused on the development of innovative medicines to treat and prevent infectious diseases. With a primary focus on orthopoxviruses, we are dedicated to protecting humanity against the world's most severe infectious diseases, including those that occur naturally, accidentally, or intentionally. Through partnerships with governments and public health agencies, we work to build a healthier and safer world by providing essential countermeasures against these global health threats. Our flagship product, TPOXX® (tecovirimat), is an antiviral medicine approved in the U.S. and Canada for the treatment of smallpox and authorized in Europe, the UK, and Japan for the treatment of smallpox, mpox (monkeypox), cowpox, and vaccinia complications. For more information about SIGA, visit Contacts:Suzanne Harnettsharnett@ and Investors Media Jennifer Drew-Bear, Edison GroupJdrew-bear@ Holly Stevens, CG Lifehstevens@
